Celldex Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,175 | $3,191 | $2,498 | $156 |
Gross Profit | 1,175 | 3,191 | 1,701 | -619 |
EBITDA | -55,208 | -51,340 | -45,520 | -39,833 |
EBIT | -56,027 | -52,126 | -46,317 | -40,608 |
Net Income | -47,092 | -42,121 | -35,842 | -32,808 |
Net Change In Cash | 1,175 | 3,191 | 2,498 | 156 |
Free Cash Flow | -33,232 | -54,719 | -29,601 | -40,982 |
Cash | 28,356 | 36,399 | 42,739 | 115,077 |
Basic Shares | 64,395 | 66,294 | 66,019 | 58,871 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $7,020 | $6,883 | $2,357 | $4,651 |
Gross Profit | 7,020 | 3,875 | 957 | 1,583 |
EBITDA | -191,901 | -139,034 | -104,200 | -66,080 |
EBIT | -195,078 | -142,042 | -105,600 | -69,148 |
Net Income | -157,863 | -141,429 | -122,783 | -70,511 |
Net Change In Cash | 7,020 | 6,883 | 2,357 | 4,651 |
Cost of Revenue | -4,693 | |||
Free Cash Flow | -157,778 | -109,109 | -105,560 | -62,158 |
Cash | 28,356 | 34,814 | 29,429 | 39,143 |
Basic Shares | 64,395 | 48,449 | 46,888 | 42,870 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.71 |
2024-09-30 | -$0.64 |
2024-06-30 | -$0.54 |
2024-03-31 | -$0.56 |
